Amphastar Pharmaceuticals Inc (AMPH):企業の財務・戦略的SWOT分析

◆英語タイトル:Amphastar Pharmaceuticals Inc (AMPH) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH94919FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:55
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Amphastar Pharmaceuticals Inc (AMPH) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Amphastar Pharmaceuticals Inc (Amphastar) is a specialty pharmaceutical company that develops, manufactures and markets generic and proprietary injectable, intranasal and inhalation products. It sells insulin active pharmaceutical ingredient products. The company’s key products include enoxaparin sodium injection; cosyntropin for injection; naloxone hydrochloride (HCl) injection and phytonadione injection; lidocaine jelly; amphadase hyaluronidase injection; Primatene Mist and lidocaine jelly. Amphastar offers its products to alternate care sites, hospitals, clinics and doctors’ offices and long-term care facilities. The company markets its products through subsidiaries, specialty distributors, wholesalers and retailers in the US, the UK, France and China. Amphastar is headquartered in Rancho Cucamonga, California, the US.

Amphastar Pharmaceuticals Inc Key Recent Developments

Apr 06,2021: Amphastar Pharmaceuticals to Present at the 20th Annual Needham Virtual Healthcare Conference
Mar 15,2021: Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2020
Mar 08,2021: Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 15th, 2021
Feb 26,2021: Amphastar Pharmaceuticals to Present at the Raymond James 2021 Institutional Healthcare Conference
Nov 06,2020: Amphastar Pharmaceuticals reports financial results for the three months ended September 30, 2020

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Amphastar Pharmaceuticals Inc – Key Facts
Amphastar Pharmaceuticals Inc – Key Employees
Amphastar Pharmaceuticals Inc – Key Employee Biographies
Amphastar Pharmaceuticals Inc – Major Products and Services
Amphastar Pharmaceuticals Inc – History
Amphastar Pharmaceuticals Inc – Company Statement
Amphastar Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Amphastar Pharmaceuticals Inc – Business Description
Business Segment: Active Pharmaceutical Ingredients (API)
Overview
Performance
Business Segment: Finished Pharmaceutical Products
Overview
Performance
Geographical Segment: China
Performance
Geographical Segment: France
Performance
Geographical Segment: The US
Performance
R&D Overview
Amphastar Pharmaceuticals Inc – Corporate Strategy
Amphastar Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Amphastar Pharmaceuticals Inc – Strengths
Amphastar Pharmaceuticals Inc – Weaknesses
Amphastar Pharmaceuticals Inc – Opportunities
Amphastar Pharmaceuticals Inc – Threats
Amphastar Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Amphastar Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 06, 2021: Amphastar Pharmaceuticals to Present at the 20th Annual Needham Virtual Healthcare Conference
Mar 15, 2021: Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2020
Mar 08, 2021: Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 15th, 2021
Feb 26, 2021: Amphastar Pharmaceuticals to Present at the Raymond James 2021 Institutional Healthcare Conference
Nov 06, 2020: Amphastar Pharmaceuticals reports financial results for the three months ended September 30, 2020
Aug 06, 2020: Amphastar Pharmaceuticals reports financial results for the three months ended June 30, 2020
Jun 12, 2020: Amphastar Pharmaceuticals to present at the Raymond James Virtual 2020 Human Healthcare Innovation Conference
May 07, 2020: Amphastar Pharmaceuticals reports financial results for the three months ended March 31, 2020
May 04, 2020: Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2020
Apr 13, 2020: Amphastar Pharmaceuticals announces simplification of management structure
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Amphastar Pharmaceuticals Inc, Key Facts
Amphastar Pharmaceuticals Inc, Key Employees
Amphastar Pharmaceuticals Inc, Key Employee Biographies
Amphastar Pharmaceuticals Inc, Major Products and Services
Amphastar Pharmaceuticals Inc, History
Amphastar Pharmaceuticals Inc, Other Locations
Amphastar Pharmaceuticals Inc, Subsidiaries
Amphastar Pharmaceuticals Inc, Key Competitors
Amphastar Pharmaceuticals Inc, Ratios based on current share price
Amphastar Pharmaceuticals Inc, Annual Ratios
Amphastar Pharmaceuticals Inc, Annual Ratios (Cont...1)
Amphastar Pharmaceuticals Inc, Annual Ratios (Cont...2)
Amphastar Pharmaceuticals Inc, Interim Ratios
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Amphastar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Amphastar Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Amphastar Pharmaceuticals Inc (AMPH):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Crew Energy Inc (CR):企業の財務・戦略的SWOT分析
    Summary Crew Energy Inc (Crew Energy) is an exploration and production company that offers our long-term production and development of crude oil and natural gas resources. The company offers exploration, development, strategic acquisitions, operations, management, and production programs. It operate …
  • sanofi-aventis US LLC-製薬・医療分野:企業M&A・提携分析
    Summary Sanofi-Aventis US LLC (Sanofi US), a subsidiary of Sanofi is a drug company that discovers, develops and distributes various therapeutic solutions. The company provides prescription products, vaccines and other products. Sanofi US’s vaccines include ActHIB, Adacel, DAPTACEL, Decavac, Fluzone …
  • Enercon Services Inc:企業の戦略的SWOT分析
    Enercon Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • CNX Resources Corp (CNX):企業の財務・戦略的SWOT分析
    CNX Resources Corp (CNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Cytodyn Inc (CYDY):製薬・医療:M&Aディール及び事業提携情報
    Summary Cytodyn Inc (Cytodyn) is a clinical-stage biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies t for the treatment of Human Immunodeficiency Virus (HIV) infections. The company's products pipeline include PRO 140, Cytofe …
  • Unilever Ghana Ltd.:企業の戦略・SWOT・財務情報
    Unilever Ghana Ltd. - Strategy, SWOT and Corporate Finance Report Summary Unilever Ghana Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Royal Orchid Hotels Ltd
    Royal Orchid Hotels Ltd - Strategy, SWOT and Corporate Finance Report Summary Royal Orchid Hotels Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Venus Remedies Ltd (VENUSREM)-製薬・医療分野:企業M&A・提携分析
    Summary Venus Remedies Ltd (Venus) is a pharmaceutical company that develops, manufactures and commercializes research, herbal and generic products. The company manufactures complex formulations for oncology injections, neurology, antiseptic, pain management, anti infectives, oncology lyophilized, l …
  • Cooper-Standard Holdings Inc.
    Cooper-Standard Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Cooper-Standard Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Petratherm Ltd (PTR):電力:M&Aディール及び事業提携情報
    Summary Petratherm Ltd (Petratherm) is a renewable energy company that carries out the business of exploration and development of emission-free geothermal energy projects. The company holds interest in Paralana Geothermal Energy Project located 600 km north of the city of Adelaide in South Australia …
  • Norsk Hydro ASA (NHY):電力:M&Aディール及び事業提携情報
    Summary Norsk Hydro ASA (Hydro) is a global supplier of aluminum and an electricity producer. Its operations span the value chain, from bauxite extraction to the production of rolled and extruded aluminum products and building systems. Its portfolio of products include bauxite, alumina, extrusion in …
  • Abbott India Ltd (ABBOTINDIA):製薬・医療:M&Aディール及び事業提携情報
    Summary Abbott India Ltd (Abbott India), a subsidiary of Abbott Laboratories discovers, develops, manufactures and markets branded generic pharmaceuticals, diagnostics tools, medical devices and nutritionals. Its product portfolio encompasses multi-specialty drugs, vitamins and a comprehensive range …
  • GS Yuasa Corp (6674):企業の財務・戦略的SWOT分析
    GS Yuasa Corp (6674) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Hrvatski Telekom d.d. (HT-R-A):企業の財務・戦略的SWOT分析
    Hrvatski Telekom d.d. (HT-R-A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • United Utilities Group Plc (UU):電力:M&Aディール及び事業提携情報
    Summary United Utilities Group PLC (United Utilities) is a provider of water and wastewater services. It gathers water from reservoirs, lakes, boreholes and streams; and collects and treats wastewater, and deposits it into rivers and sea. The company extracts water from Lake Vyrnwy in Wales for cust …
  • Vitrolife AB (VITR):企業の財務・戦略的SWOT分析
    Summary Vitrolife AB (Vitrolife) is a developer, producer and marketer of laboratory products. The company provides products such as Oocyte retrieval needles, sperm processing, culture media, culture oil, additional culture media, micromanipulation solutions, vitrolife labware, micromanipulation pip …
  • Pt Bakrieland Development Tbk:企業の戦略・SWOT・財務分析
    Pt Bakrieland Development Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Bakrieland Development Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Union Investment Group:企業の戦略・SWOT・財務情報
    Union Investment Group - Strategy, SWOT and Corporate Finance Report Summary Union Investment Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Shinhan Bank:企業のM&A・事業提携・投資動向
    Shinhan Bank - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Shinhan Bank Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Prognomix Inc:企業の製品パイプライン分析
    Summary Prognomix Inc (Prognomix) is a personalized medicine company that develops molecular diagnostic test for detection of risks to develop renal, ocular, cardiac, cerebral, vascular and other complications of diabetic disease. The company’s products include PGX IR01, PGx GR01, PGx CD01, PGx IR02 …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆